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                                                         ABSTRACT 
TOPIC 
A study on ophthalmic manifestations of migraine 
AIMS AND OBJECTIVES 
1.To elucidate the various ophthalmic manifestations of different types of migraine 
2.To assess the response to treatment (with steroids ) in ophthalmoplegic migraine. 
3.To assess the visual field changes in migraine 
4.OCT changes in migraine 
5.To find out any association with other ocular disorders. 
INCLUSION CRITERIA 
1.Patients with migraine (migraine with aura and migraine without aura). 
2.Retinal migraine 
3.Ophthalmoplegic migraine 
 EXCLUSION CRITERIA 
Any other type of headache other than migraine,refractive errors,head or eye trauma, 
eyes with retinal or optic disc pathology,cataract,corneal opacity,ocular laser treatment,CNS 
disorders like tumors,infarcts,diabetic and hypertensive retinopathy 
AGE:5 to 60 years  
STUDY DESIGN:Prospective clinical study 
NUMBER OF PATIENTS:50 
CONCLUSION 
The mean age of presentation was 40.58 years of age.Females were  more commonly 
affected.Visual phenomena associated with migraine was present in 30% of patients with 
migraine.Photophobia in 18% of patients. RNFL thinning was noted by OCT in BE- 50% of 
patients(single quadrant thinning),RE:8% of patients(single quadrant thinning),LE:8% of the 
patients(single quadrant thinning),multiple quadrant thinning:2% of patients. Patients with 
ophthalmoplegic migraine responded to treatment with steroids and completely recovered in 
2 months.This proved that ophthalmoplegic migraine is an inflammatory demyelinating 
neuropathy.The mean age of presentation was 5 years of age in our study. 
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GENETICS 
Several factors allude to a genetic basis for migraine based on twin 
studies,family studies of rare genetic variations of migraine.Monozygotic twin 
studies have a higher concordance rate for migraine than dizygotic twin 
studies.Genes have been identified in some patients with rare forms of migraine 
such as familial hemiplegic migraine(CACNA1A subunit on chromosome 19p13). 
Overall there is no specific pattern of inheritance and multifactorial 
inheritance(environmental and genetic) plays a role.  
MECHANISM  
The aura symptoms of migraine are likely caused by cortical spreading 
depression(CSD).CSD involves initial neuronal hyperpolarisation.During this time 
positive symptoms occur and there is increased regional cerebral blood flow.The 
wave of hyperpolarisation is followed by depolarisation,leading to negative aura 
symptoms.Aura symptoms are produced in relation to the areas of cerebral cortex 
affected. 
Primary and visual association areas : Visual symptoms 
Parietal cortex: Somatosensory symptoms 
Motor cortex: Weakness 
The  dynamic  nature  of  CSD  correlates  with  the  speed  of  scintillating  
scotoma moving across the visual field and explains the typical march of migraine 
aura symptoms. 
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PATHOPHYSIOLOGY 
The pain of migraine is linked to the pain sensitive structures in the brain, the 
dura and cranial blood vessels. These structures are innervated by the first division 
of trigeminal nerve(ophthalmic) anteriorly and branches of C1 and C2 posteriorly. 
The interaction among the trigeminal nerve, autonomic nerves and blood vessels is 
referred to as trigeminovascular system. The central trigeminovascular neurons 
receive multiple sensory inputs from the meninges and the periorbital tissues. When 
activated by meningeal nociceptors, the central neurons may misinterpret the pain as 
originating in or near the eye causing the referred periorbital pain of migraine.  
 When neurons are activated, inflammatory molecules(substance P,calcitonin 
gene related peptide, vasoactive intestinal peptide) are released near meningeal 
blood vessels, activating meningeal nociceptors and producing vasodilation,plasma 
extravasation, mast cell degranulation and platelet aggregation. This creates a 
condition of sterile inflammation around dural blood vessels. Within 5-20 min of a 
migraine headache, peripheral nociceptors are sensitised, producing a burst of action 
potentials in response to cerebrospinal fluid pulsations and leading to throbbing 
pain. Between 20 minutes and 2 hours after a migraine attack central neurons are 
sensitised and produce a heightened response to otherwise innocuous stimuli.This 
phenomenon, cutaneous allodynia, accounts for facial and scalp tenderness that 
occurs during migraine 
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PATHOPHYSIOLOGY OF ASSOCIATED SYMPTOMS 
Brain structures such as dorsal raphe nucleus, nucleus raphe magnus and 
trigeminal nucleus caudalis project to various areas of the brain and spinal cord to 
further modulate the pain and other symptoms of migraine. Connections through the 
superior salivatory nucleus to the pterygopalatine ganglion may be responsible for 
ocular autonomic features of migraine such as lacrimation, lid edema and 
conjunctival injection. Hypothalamic projections may mediate the episodic pattern 
of attacks in some headache disorders as well as changes in arousal. Input to the 
frontal cortex may lead to difficulty concentrating and emotional changes associated 
with migraine. Migraine pain is modulated through the thalamus.The trigeminal 
nucleus  caudalis  and  dorsal  horn  of  C1  and  C2  also  contribute  to  the  pain  of  
migraine particularly posterior head and neck. 
CLINICAL FEATURES 
Migraine may begin at any age and is not rare in infancy and early 
childhood. Additionally the character of migraine often changes throughout life. 
Women commonly experience a shift in their migraine pattern during times of 
hormonal fluctuation, such as menarche, pregnancy and menopause. 
Patients who experienced migraine pattern with aura in adolescence or young 
adulthood may have improvement in headaches but experience recurrent aura 
symptoms as they get older. 
A fully developed migraine attack can be divided into four phases,each of 
which may have ophthalmic manifestations: 
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Premonitory phase: 
Symptoms occurring hours to days before a migraine attack that may include 
depression, sleep disorders, hypoactivity or arousal, abdominal discomfort, food 
carvings, epiphora, dulled or heightened mentation, uncontrollable yawning, 
heightened perceptions of taste and smell and visual difficulties. 
Aura: 
Focal neurological symptoms immediately preceding and sometimes 
accompanying the headache. It is present only in 20% of the patients. 
Headache: 
mild, moderate, severe 
Postdrome: 
Post headache alteration of mood or mentation, difficulty concentrating including 
drowsiness, lethargy or epiphora. Symptoms may last upto 24 hours. 
The most common symptom of migraine is pulsatile pain present in 85 % of 
patients followed by photophobia(76%) and nausea(74%). 
Hemicranial pain occurs in 59% of patients. 
Worsening of headache with physical activity is characteristic of migraine 
which distinguishes from other types of headache.  
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Figure 1:Phases of migraine 
OPHTHALMIC SYMPTOMS & SIGNS: 
Typically ophthalmic features of migraine occur during the aura phase but 
they may occur at any time during the migraine period. Blurred vision, a non 
specific feature of migraine occurs in 40% of patients at some point of time during  
migraine. The major types of ophthalmic symptoms are positive symptoms, negative 
symptoms, autonomic manifestations and efferent symptoms or signs 
POSITIVE SYMPTOMS 
Seeing shapes or lights that are not present is the most typical manifestation 
of migraine aura. The characteristic scintillation scotoma with fortification spectra is 
virtually pathognomic of migraine. It generally begins as a paracentral shimmering 
effect that enlarges and expands over the hemifield. The illusion may be colourful or 
silver and black. The periphery takes on a jagged or herring bone pattern that 
shimmers  or  scintillates.  An  area  of  relative  or  absolute  scotoma  is  frequently  
observed within the confines of the shimmering border. The rate of progression of 
the scintillating scotoma across the visual field corresponds to the rate of cortical 
spreading depression across the visual cortex 3mm/min. This symptom usually lasts 
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10 – 30 min and frequently heralds a headache attack. Other positive symptoms 
include light flashes, sparkles, kaleidoscope vision, fragmented vision(like cracked 
glass) and a sensation of heat waves. 
Cortical visual disturbances (similar to those of epilepsy) include 
metamorphopsia, micropsia or macropsia, Alice in Wonderland syndrome, mosaic 
vision. 
NEGATIVE SYMPTOMS 
Homonymous hemianopic or quadrantanopic visual field defect.Tunnel 
vision sometimes progressing to complete blindness may occur. 
AUTONOMIC FEATURES 
These features define trigeminal autonomic cephalgias during a migraine 
attack. Horners syndrome, conjunctival injection, mild ptosis and eyelid edema may 
accompany nasal congestion or rhinorrhea. The nasal symptoms often lead to 
erroneous diagnosis of sinus headache. Transient anisocoria may be a part of 
migraine attack either in isolation or with an oculomotor nerve palsy or Horners 
syndrome 
OTHER NEUROLOGICAL SYMPTOMS 
These  features  are  much  less  common  and  may  be  a  part  of  aura  or  a  
manifestation of basilar type of migraine. Diplopia may be a symptom of basilar 
type of migraine (Bickerstaffs migraine) which often affects adolescent girls but 
may affect both males and females of all ages.Other symptoms of this uncommon 
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migraine are vertigo, tinnitus, hearing impairment, ataxia, impaired cognition and 
altered level of consciousness. Bilateral symptoms and signs are typical such as 
paresthesias and numbness. 
OTHER FEATURES 
Photosensitivity, persistent positive visual phenomena (“visual snow”), 
difficulty tolerating a busy environment, cortical blindness, visual distortion(“heat 
off the pavement”), isolated papillary mydriasis 
MIGRAINE VARIANTS 
RETINAL MIGRAINE(OCULAR MIGRAINE) 
Ocular (retinal) migraine consists of monocular visual symptoms with or 
without associated headache. The terminology is confusing and it is often 
mistakenly used to describe a visual aura of cortical origin or the presence of 
binocular aura(eg., homonymous hemianopia) without headache. When obtaining 
the description of symptoms from the patient, it is helpful to ask what they observed 
when they covered or closed either eye. In case of visual loss, an accounting of their 
vision when looking straight ahead with both eyes open usually distinguishes 
monocular from binocular visual loss. 
The International Headache Society classification specifies atleast two 
reversible attacks lasting less than 60 minutes associated with migraine 
headache. Visual symptoms may be positive or negative. When headache occurs, 
the visual loss is generally ipsilateral to the pain.. 
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Young women are frequently affected.  It  is  controversial  whether  it  is  
pathophysiologically related to more typical migraine. Unilateral visual loss which 
is transient in nature may occur. This may resemble amaurosis fugax from 
thromboembolic disease. 
These  spells  are  generally  painless  and  thus  do  not  meet  strict  criteria  for  
ocular migraine. They last seconds to hours ,usually 5-45 min and are described as a 
monocular shade, curtain, or tunnel vision. The spells often come in a flurry in the 
sixth or seventh decade. Many patients have a prior history of migraine headaches 
but these late life episodes may occur in previously asymptomatic patients. 
ASSOCIATIONS 
Narrowing or occlusion of retinal arteries or veins has been observed in some 
cases. Ischaemic optic neuropathy, retinal vein occlusion, retinal or optic nerve 
haemorrhages may be noted in some cases. Although visual loss during ocular 
migraine is generally reversible, permanent visual loss sometimes occurs. Thus 
preventive treatment with calcium channel blockers ,low dose aspirin or other 
migraine prophylactic medications may be warranted 
BENIGN EPISODIC PUPILLARY MYDRIASIS 
It is an uncommon condition characterised by unilateral episodic mydriasis 
lasting minutes to a week. It may be associated with headache or orbital pain but is 
frequently painless. It is likely a migraine variant since over 50% of patients have a 
history of migraine. The involved pupil is usually poorly reactive or unreactive to 
light and near stimuli, and does not constrict with pilocarpine. Differential diagnosis 
includes Adies tonic pupil, pharmacologic mydriasis and early oculomotor nerve 
compression. 
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OPHTHALMOPLEGIC MIGRAINE 
COMMON AGE GROUP AFFECTED: paediatric age group, commonly 5 to 8 yrs 
INCIDENCE:0.9/1,000,000  
Ophthalmoplegic migraine is an ocular disorder which is characterised by 
ophthalmoplegia following many episodes of migraine. The disorder always begin 
in childhood. Isolated Oculomotor nerve palsy is common. Pupil involvement is the 
rule. Abducent and trochlear nerve palsies are rare. Prognosis is good as symptoms 
usually resolve. 
It is not a true migraine so removed from International Headache Society 
classification of migraine. Headache resolves over a few days but cranial neuropathy 
may take weeks to resolve. It may continue to adulthood. 
PATHOPHYSIOLOGY 
Earlier it was thought that during the attack, carotid artery wall becomes 
edematous. This compresses the oculomotor nerve in the cavernous sinus and causes 
third nerve palsy. The latest finding is that ophthalmoplegic migraine is an 
inflammatory demyelinating neuropathy of third nerve which also irritates the fifth 
nrve roots present in the same nerve. GdMRI proves that the oculomotor nerve 
becomes reversibly enhanced, especially the cisternal portion. 
CLINICAL FEATURES 
Usually patients complain of headache, drooping of upper lid, double vision 
(if no drooping) of sudden onset for short duration of about a week or 10 days. 
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Headache is usually more in the frontal region and is usually associated with 
projectile vomiting and head banging which suggestive of temper tantrums. There is 
intolerance to noisy environment and headache is usually throbbing in nature. There 
is usually a past history of previous migraine headaches for which the patient would 
have taken medications. There will be associated 3rd(most common),4th or 6th cranial 
nerve palsies. 
DIFERENTIAL DIAGNOSIS 
1. Aneurysm 
2. Infections(eg.,Lyme disease,syphilis,HIV) 
3. Microvascular cranial mononeuropathy 
4. Lymphoma 
5. Leukemia 
6. Tolasa Hunt Syndrome 
7. Sarcoidosis 
8. Sphenoid sinusitis 
MRI FINDING 
Enhancement of third nerve on MRI is frequently observed. 
INVESTIGATIONS 
1. Baseline investigations like complete blood count(Hb,TC,DC,platelet count, 
PCV), blood urea , serum creatinine, serum sodium. potassium, SGOT, 
SGPT, X ray chest. 
2. Vasculitis work up:ESR,CRP.ANA,ANCA,RF. 
3. Thyroid profile:T3,T4,TSH. 
4. Lumbar puncture and CSF analysis.  
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5. Metabolic parameters like serum lactate,ammonia,urine porhyrin. 
6. Complement factors. 
7. ECG,echocardiogram. 
8. MRI. 
MANAGEMENT 
Medications for migraine (eg.,T.Propranalol). 
Antidepressants like T. Amitryptilline 
Steroids(1 mg/kg bodyweight) and slowly tapered. 
Complete recovery is the rule 
ASSOCIATED VISUAL FEATURES OF MIGRAINE 
VISUAL SNOW 
Visual snow is the most perplexing and frustrating condition characterized 
by persistent positive visual phenomena which most commonly occurs in 
migraineurs. Patients describe snow, ants dots or rain continuously encompassing 
the entire visual field. Complex illusions have also been reported. Visual snow 
frequently occurs in high functioning, observant individuals. They are able to see 
through the static but it is distracting and annoying. It may persist for many years. 
Neuro-imaging studies are unrevealing and treatment is usually unsatisfactory. The 
pathophysiology is uncertain but spontaneous cortical discharges, persistent 
hyperexcitability of the visual cortex and a heightened awareness of normal visual 
phenomena are postulated. 
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PHOTOPHOBIA 
Photophobia is an abnormal sensitivity to light which is one of the diagnostic 
criteria for migraine. It is present in 80% of patients during a migraine headache. It 
may also be a part of the aura or premonitory symptom of migraine. Additionally 
patients with migraine have more light sensitivity than control patients in between 
attacks. 
Photosensitivity is the visual system analog of allodynia which occurs in 
other neurological sensory systems during migraine (allodynia is the painful 
perception of a stimulus that is generally not painful).Photophobia often occurs 
during a migraine attack particularly chronic cases. As with other forms of allodynia 
the stimulus may also be a migraine trigger. Bright lighting such as sunlight, 
fluorescent light, bright snow or flickering lights triggers migraine attacks in 30-
60% of migraineurs. Many patients also have a heightened sensitivity to complex 
visual patterns or a busy visual environment in between attacks. Sympathetic 
stimulation and down regulation of visual thresholds by the trigeminal nerve usually 
occurs. 
VISUAL PHENOMENA ASSOCIATED WITH MIGRAINE 
FORTIFICATION SPECTRA 
Arc of jagged, serrated or zigzag lines. They are also caused by occipital 
AVM, seizures and space occupying lesions. 
 
13 
SCINTILLATING SCOTOMA 
Positive fortification spectra on outside and negative scotoma in the middle. 
They are also caused by seizures, occipital AVM, and space occupying lesions. 
MICROPSIA 
Objects appear too small. It is also caused by seizures, occipital AVM, space 
occupying lesion and macular disease. 
MACROPSIA 
Objects appear large. It is also seen in seizures, occipital AVM, and space 
occupying lesion. 
METAMORPHOPSIA 
Objects appear distorted in shape. It is also seen in macular disease and 
seizures. 
“ALICE IN WONDERLAND SYNDROME” 
Episodes of distorted body image. It is also seen in seizures, occipital AVM, 
and space occupying lesions. 
PALLINOPSIA 
Persistence of visual images. Also seen in seizures,parieto occipital damage 
and some medications. 
CEREBRAL POLYOPIA 
Perception of multiple images in both eyes. Also seen in seizures and right 
occipital damage 
ACHROMATOPSIA 
Inability to perceive colour.  Also seen in bilateral occipito temporal damage. 
14 
                           
 
 
 
 
 
 
 
 
 
Figure 2 : Scintillation scotoma which is the characteristic visual  
 feature of migraine. 
Figure 2a : Scintillation scotoma initially appears as a small  
 paracentral visual disturbance 
Figure 2b&c : Scintillation scotoma then starts expanding over one 
hemifield 
Figure 2d : Scintillation scotoma then breaks up in the periphery 
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OTHER TYPES OF MIGRAINE 
MIGRAINE ASSOCIATED WITH HEMIPLEGIA 
This type of migraine is recurrent and familial.It is associated with aura and 
motor weakness. 
INHERITANCE: 
Autosomal dominant with variable penetrance 
ONSET: 
Typically in childhood and nearly always by the age of 30 yrs 
GENETICS: 
Familial hemiplegic migraine type 1 localises to chromosome 19 and type 2 
is localized to chromosome 1. 
CLINICAL FEATURES: 
1. Typical aura 
2. Disturbance of consciousness 
3. Fever 
4. CSF pleocytosis 
5. Confusion during an attack 
6. MRI brain is normal 
 
16 
TREATMENT 
Differs from other forms of migraine. Medications with vasoconstrictor 
effects are best avoided. Treatment is usually with intravenous dopamine agonists, 
calcium channel blockers and acetazolamide. 
BASILAR TYPE OF MIGRAINE 
Migraine is recurrent.Aura is usually present.Weakness is absent.Cerebral 
hemispheres or medulla or pons is involved.It is usually rare and should only be 
diagnosed after vertebrobasilar ischaemia has been ruled out. 
TENSION TYPE HEADACHE(TTH) 
TTH is an important differential  diagnosis for migraine.  Migraine and TTH 
may be found in the same patient. Muscle tension is often considered as a unique 
feature of  TTH, while migraine is commonly felt not to be associated with muscle 
tension or neck pain. 
CLASSIFICATION 
Episodic TTH and chronic TTH 
EPISODIC TTH 
Episodic TTH is characterized by headache which occurs frequently. 
Headache is usually bilateral. Headache is not related to routine physical activity. 
There is no nausea or vomiting. Photophobia or phonophobia may occur. The 
headaches occur fewer than 15 days a month for atleast 3 months. 
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CHRONIC TTH 
In chronic TTH, the frequency of headache is increased. They occur greater 
than 15 days a month. This usually happens for a minimum of three months 
continuously. 
PATHOPHYSIOLOGY 
TTH occurs due to sustained contraction of pericranial muscles. Peripheral 
pain mechanisms act as a trigger for a central process. Peripheral mechanisms may 
be most important in episodic TTH while in chronic TTH, central mechanisms may 
predominate. 
TREATMENT 
Acute therapy typically involve the structured use of simple analgesics 
(acetaminophen,  aspirin),alone  or  in  combination  with  NSAIDS.  Overuse  of  these  
drugs must be limited. Prophylactic therapy must be considered when the frequency 
and duration of the headache is prolonged and over use is suspected. Tricyclic anti-
depressants can be used for prophylactic therapy. 
INVESTIGATIONS AND CLINICAL WORK UP 
HISTORY 
Detailed history taking is carried out in evaluating the ophthalmic features of 
migraine. History of diurnal variations, presence or absence of aura is asked. History 
of any associated symptoms like nausea, vomiting is asked .Patients with 
ophthalmoplegic migraine are carefully evaluated. As these patients are children, 
parents or guardians from whom the history taking is reliable is selected for the 
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study. Drug and treatment history is asked and duration of illness is also one of the 
most important parameters to be asked for.Triggers of migraine are 
1.Emotional stress 
2.Hormonal changes in women 
3.Weather 
4.Sleep disturbances 
5.Odours 
6.Lights 
7.Alcohol 
8.Smoking 
9.Sleeping late 
10.Heat 
11.Food 
12.Exercise 
Past history of diabetes, hypertension, bronchial asthma,COPD,coronary 
artery disease, tuberculosis, renal disorder, thyroid disorder drug abuse is important. 
Personal history of smoking, alcoholism, diet intake is asked. Family history of 
migraine is asked. 
GENERAL EXAMINATION AND INVESTIGATIONS 
Pulse rate, BP, respiratory rate, temperature are recorded. Systemic examination of 
cardiovascular system, respiratory system, abdomen, central nervous system is 
done.General investigations like blood sugar, hemoglobin, total count, differential 
count, lipid profile, ESR done.   
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OPHTHALMIC INVESTIGATIONS 
VISUAL ACUITY 
Visual acuity is tested using snellens visual acuity charts 
COLOUR VISION 
Colour vision is a perceptual phenomenon not just a physical property of an 
object. There are three different types of cones: red sensitive (erythrolabe),green 
sensitive (chlorolabe) and blue sensitive (cyanolabe),which combinedly perform the 
function  of  colour  vision.  All  colours  are  a  result  of  admixture  in  different  
proportion of the three primary colours: 
1.Red(723-647 nm) 
2.Green(575-492 nm) 
3.Blue(492-450 nm) 
Colours have 3 attributes:hue, intensity and saturation. 
A  normal  person  can  see  all  wavelengths  between  violet  to  red.  If  the  
wavelength is shorter than that of violet, the light becomes ultraviolet(UV) and is 
beyond visibility. If the wavelength is greater than 750 nm,the light is infrared and is 
again beyond visibility. Human beings could have seen even UV light as blue cones 
retain some sensitivity at around 10 nm, but crystalline lens blocks all UV rays. 
Consequently after cataract surgery one can see UV rays to an extent. 
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The photochemical changes in the cone pigments followed by a cascade of 
biochemical changes produce a visual signal in the form of “cone receptor 
potential”. Cone receptor potential has a sharp onset but slow offset. It is transmitted 
to the other cells of retina across the synapses of photoreceptors, bipolar cells and 
horizontal cells. Then it is transmitted across the synapses of bipolar cells,ganglion 
cells and amacrine cells. 
Trichromatic colour vision mechanism extends 20 – 30 degrees  from the 
point of fixation. Peripheral to this red and green becomes indistinguishable and in 
the far periphery all colour sense is lost, although cones are still found in the region 
of retina. 
Hue is the dominant spectral colour as determined by the wavelength of the 
particular colour. The lightness or brightness of the colour depends upon the 
luminosity of the component wavelength. In photopic vision(day light),normal eye 
has a peak luminosity function at approximately 555 nm and in scotopic vision(dim 
light) at about 507 nm. This wavelength shift is called “Purkinje shift”.Saturation 
refers to degree of freedom from dilution with white.It can be estimated by 
measuring how much of wavelength must be added to white before it is 
distinguishable from white. The more the wavelength to be added to make the 
discrimination, the lesser the saturation and vice versa. 
TESTS FOR COLOUR VISION IN MIGRAINE 
A chromatopsia is a visual phenomenon associated with migraine.Ishihara’s 
colour vision plates are used in RIOGOH for testing colour vision of the patients 
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REFRACTION 
Refraction should be done in all patients with migraine.If the patients are 
above 40 years, full presbyopic correction should be given.Retinoscopic refraction 
done for all patients to rule out refractive errors as headache may be because of 
refractive errors. 
Drug used is 
1-5 years:1% atropine eye drops. 
5-8 years:2% homatropine eye drops. 
8-20 years:1 % cyclopentolate hydrochloride eye drops. 
Above 20 years:0.5% or 0.8% tropicamide eyedrops. 
SLIT LAMP BIOMICROSCOPIC EXAMINATION 
Slit lamp examination is done for all patients with migraine. It helps to rule 
out anterior segment diseases of the eye like conjunctivitis, lid disorders( blepharitis, 
meibomitis), keratitis,uveitis ,cataracts. 
INTRAOCULAR PRESSURE 
Measurement of intraocular pressure is one of the routine investigations in 
migraine.  It  also  helps  us  to  find  whether  migraine  is  associated  with  other  ocular  
disorders like glaucoma. Goldmann’s applanation tonometer is the gold standard in 
measuring intraocular pressure. 
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FUNDUS EXAMINATION 
Fundus examination should be done in all patients with migraine. All 
patients are dilated using 0.8% Tropicamide eye drops and detailed fundus 
examination should be done. The following points are given importance while 
performing the fundus examination: 
1.Disc changes: 
The disc should be examined for its size, shape, colour, margins and cup-disc 
ratio. This is helpful to rule out other ocular disorders like glaucoma. 
2.RNFL changes: 
RNFL layer changes in all quadrants (superior, inferior, nasal and temporal) can be 
found out clinically using red free filter provided in the direct ophthalmoscope. Its 
helpful in assessing the RNFL layer changes in migraine 
3.Macula: 
Macula is examined using direct,indirect and slit lamp biomicroscopy with 
90D lens. It is to rule out any other macular disorders like degenerations, holes, 
epiretinal membranes or dystrophies. 
4.Peripheries: 
The peripheral retina is examined using indirect ophthalmoscopy with 20D 
lens. This is done to rule out peripheral retinal diseases like retinal degenerations, 
detachments, breaks or holes. 
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GONIOSCOPY 
Gonioscopy  is used to study the angle structures of the eye. Because of total 
internal reflection, angle structures of the eye cannot be visualized by naked eye. So 
we use a gonioscopic lens to visualize the angle structures. It helps us to find 
whether the angles are open or closed. Thereby we can also find whether migraine is 
associated with ocular disorders like glaucoma. Direct or indirect lens can be used. 
Indirect  lens helps us to grade the opposite angles and direct lens helps us to grade 
the angles in the same quadrant. Indirect lens may or may not use a coupling fluid. 
SHAFFERS GRADING OF ANGLES 
GRADE STATUS ANGLE STRUCTURES VISIBLE 
4 
Wide open (40 
degrees) 
Ciliary body band, scleral spur, trabecular 
meshwork, Shwalbe’s line 
3 Open (30 degrees) 
Scleral spur, trabecular meshwork, 
Shwalbes line 
2 
Moderately narrow 
(20 degrees) 
Trabecular meshwork, Shwalbe’s line 
1 Narrow (10 degrees) Shwalbe’s line only 
0 Closed (0 degrees) No angle structures visible 
 
AUTOMATED PERIMETRY 
Standard Automated Perimetry using an adaptive forecasting threshold 
technology for central visual field remains the preferred visual field testing method. 
Neuro-ophthal fields for migraine can also be evaluated using automated perimetry. 
It tells us about the visual field changes in migraine and also whether migraine is 
associated with other disorders like glaucoma. 
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Automated  tests  utilizes  computer  programs  to  vary  test  speed,  target  size  
and luminance. They also benefit from standardized testing conditions which can be 
used to interpret results across machines. They present light stimuli of varying 
luminance to the patient on specific locations for a given duration of time before the 
next stimuli is presented. 
Both static and kinetic testing can be performed manually. Manual kinetic 
perimetry is more flexible and interactive for the patient and it provides the 
opportunity to evaluate the peripheral visual fields. 
PROGRAM TESTS: 
Test procedures to evaluate the macular region ,the central 30 degrees radius 
and the far peripheral visual field beyond 30 degrees are available. A variety of 
target sizes, durations and test presentation patterns can be selected.  
OPTICAL COHERENCE TOMOGRAPHY(OCT) 
The three dimensional structure of the optic nerve head and the peripapillary 
thickness of the retinal nerve fibre layer(significant in migraine) can be assessed 
quantitatively with precision using OCT. 
OCT is a high resolution cross sectional imaging of the RNFL.It measures 
the intensity and echo time delay of back scattered and back reflected light from the 
scanned tissues. 
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PRINCIPLE : 
Based on principle of Michelsons interferometry where low coherence 
infrared light is coupled to a fibre optic travels through a beam splitter and is 
directed through the ocular media to the retina and a reference mirror. The distance 
between the beam splitter and the reference mirror is continuously varied. When the 
distance between the light source and the retinal tissue = distance between the light 
source and reference mirror, the reflected light interacts to produce an interference 
pattern. The interference is measured by a photodetector and processed into a signal. 
A two dimensional image is built as the light source moves along the retina.The 
interferometer integrates several data points over 2 mm depth to construct a 
tomogram of the structures. 
TYPES AND DIFFERENCES 
OCT may be time domain or spectral domain. 
TIME DOMAIN OCT 
1. In time domain OCT, the reference mirror moves back and forth. It moves 
one cycle for each axial scan so limits the speed of image acquisition. 
2. Axial resolution is 10 microns, so takes 400 A scans/second. 
3. Its a line scan, so there is limited amount of data and there is requirement for 
data interpolation. 
4. Decentration effects occur. 
5. Eye motion artifacts occur because of lesser axial resolution and scanning 
speed. 
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SPECTRAL DOMAIN OCT 
1. In spectral domain OCT,the reference mirror is stationary and spectrometer 
analyses signal by wavelength. 
2. Axial resolution is 5 microns and takes 20,000 A scans /second 
3. Its a raster scan,so there is large amount of data and more precise 
segmentation of retinal layers 
4. It has better repeatability and reliability. 
5. There are no eye motion artifacts . 
SCANS IN MIGRAINE 
1.RNFL thickness report 
Three concentric scans each of 1.34 mm radius centered around the ONH 
acquired in rapid succession(1.9 seconds scan time),each made of 256 A scans. It 
has been shown to exibit maximum reproducibility of RNFL measurement. The 
mean RNFL thickness is calculated using age adjusted RNFL thickness average 
analysis  protocol.  Third  generation  OCT  offers  a  variety  of  RNFL  thickness  
measurement and analysis protocols like RNFL thickness circle scan,fast circle scan, 
concentric three ring protocol, RNFL map and proportional circles 
RNFL thickness is reported for clock hours, quadrants and as an overall 
average. RNFL thickness is usually superimposed on a normative database graph.In 
normal individuals RNFL thickness typically follows a “double hump” pattern. This 
is because RNFL is thicker at the inferior and superior poles of the nerve. 
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An individual patient’s RNFL thickness profile can be compared to a 
normative database that represents the averaged RNFL profile from a large group of 
healthy subjects gathered at a variety of clinical sites. This profile is adjusted for 
age, because of natural loss of RNFL thickness with age. 
In a normative database graph, 
Green section encompasses 5th to 95th percentile of normative range for 
RNFL.If the individual profile falls within the green area it is considered to be 
within normal limits. 
Yellow section represents thickness for first to fifth percentile of  the  
normal population range and is considered to be a “borderline” RNFL thickness. 
Red section represents anything less than the first percentile value and is 
considered “outside normal limits”. 
Values greater than the 95th percentile cutoff are above normal limits and 
are indicated in white 
Signal strength should be between 6 and 10.Thickness values from the three 
circumpapillary scans are averaged to generate the RNFL thickness profiles. 
So the report consists of overall thickness value, averages by quadrants, 
averages by clock hours, table with various comparisons among maximum, 
minimum, and average RNFL thickness in quadrants and overall area. 
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RNFL thinning is noted in migraine. 
OPTIC NERVE HEAD ANALYSIS REPORT 
The “Fast Optic Disc scan” pattern consists of six evenly spaced radial lines 
centered on the ONH. Each of the six lines is made of 128 A scans crossing an area 
of 4.0 mm in length and the total scan time is 1.92 seconds. 
The “Optic nerve head Analysis Report” printout shows both an individual B 
scan, which is an optical cross section that is selected by the technician. Overall grey 
scale, black and white fundus  image are also shown in the report. Signal strength 
can range from 0 to 10.It provides an indicator of the quality of the image. Signal 
strength from 6 to 10 is generally considered acceptable. 
The parameters in the “Individual Radial Scan Analysis” are primarily based 
on two automated algorithms: a segmentation algorithm that determines the location 
of the inner limiting membrane(blue line at the surface) and the one that detects the 
retinal pigment epithelium/Bruchs membrane termination(light blue circles with 
cross hairs inside). A second line in blue is drawn in parallel to the one connecting 
the two RPE/Bruch’s membrane termination points shifted up by the cup offset 
(typically 150 micrometers) to define the plane that separates the cup from the rim. 
This is shown by the red dotted line.   
The cup diameter is the horizontal distance between the two intersections of 
the  red  dotted  line  with  the  ILM  surface.  Rim  length  is  calculated  as  the  Disc  
diameter minus the Cup diameter. The rim area for the vertical cross section 
parameter is the total area of the red shaded portion of the scan.The area is bordered 
by yellow vertical lines extending up from the RPE/Bruchs membrane termination, 
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the ILM surface, and the red dotted line separating cup and the rim. The average 
nerve head width at Disc is the thickness of the nerve fibres at the disc margin, 
indicated by the yellow lines extending up from the end of the RPE. These 
parameters are calculated individually for each of the six radial scans. However they 
provide only focal information along each individual radial line and are therefore of 
limited use by themselves. 
The overall “Optic nerve head analysis results” is based on all the six radial 
scans, their segmentation and the interpolation of the data between each of the six 
radial scans. The six scans are aligned in a spoke pattern configuration and the 
smoothed lines are interpolated around the disc and cup margin points to define the 
disc(red) and cup(green).Disc and Cup area’s are areas within these margins. Rim 
area is calculated as the Disc area minus the Cup area. Cup/Disc area ratio is 
calculated as a simple ratio of the areas. The Cup/Disc horizontal and Cup/Disc 
vertical ratios are calculated by taking the maximum cup diameter in the horizontal 
or vertical direction and dividing it by the maximum disc diameter in the horizontal 
or vertical direction. The Vertical integrated rim area is essentially the red shaded 
area in the individual scans interpolated around the disc to define a rim volume.The 
Horizontally integrated rim width takes the mean of of the average nerve widths and 
multiplies the value by the circumference of the disc. 
The “Optic Nerve Head Analysis” and the” Individual radial scan analysis 
”reports along with RNFL thickness reports  are very useful in assessing whether 
migraine is associated with other disorders like glaucoma.  
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TREATMENT OF MIGRAINE 
Effective management of migraine headaches begins with making accurate 
diagnosis. Despite the fact that migraine is treatable ,many patients find themselves 
in a paradoxic situation in which they are both undertreated and overmedicated. 
They take or receive a large number of nonspecific analgesics which are minimally 
effective for migraine. It only contributes to analgesic rebound. 
Treatment includes non pharmacologic as well as pharmacologic therapy. 
Minimising excessive stress and sleep deprivation, eating regular meals, 
exercise and avoidance of common triggers (eg: wine, chocolate) are practical 
measures. Alternative therapies (biofeedback, relaxation, acupuncture) have been 
used successfully in conjunction with conventional medical treatment. 
Headache diary should be maintained by every patient. It helps the physician 
and the patient characterize the headaches more clearly. It may also give the patients 
a sense of control over their illness. 
ABORTIVE TREATMENT 
1. NSAIDS (nonsteroidal anti inflammatory drugs): 
They are appropriate agents for patients with mild to moderate migraine. 
Specific agents include acetaminophen, ibuprofen, naproxen sodium, and aspirin. 
Their effect is better when the drug is taken at the beginning of an attack, ideally 
during the prodromes. 
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2.TRIPTANS: 
Triptans act on 5 HT 1B,1D receptors. They are serotonin receptor 
agonists..They produce vasoconstriction and reduce pain. They are useful for acute 
therapy of migraine. They are useful choices for patients with moderate to severe 
migraine. Intranasal and subcutaneous forms are available for patients who cannot 
tolerate oral drugs due to nausea. Triptans are contraindicated in patients with 
cardiovascular disease. Sumitriptan is widely used in treating migraine. 
3.ERGOT ALKALOIDS: 
Dihydroergotamine (DHE) and ergotamine are members of the ergot family 
used in migraine treatment.DHE is recommended for patients with moderate to 
severe migraine. DHE can be given subcutaneously, intravenously. intramuscularly 
or intranasally. Oral or rectal ergotamine may be useful for treating patients with 
migraine. They are generally taken at the beginning of an attack 
4.OPIOID ANALGESICS: 
Oral opioids may be useful when sedation will not place the patient at risk. 
Intranasal butorphanol, a mixed opiate receptor agonist-antagonist may be useful for 
some patients but it also carries the same risk of dependency. 
5.ANTIEMETICS: 
They are often used as adjuncts to other migraine therapies. Some drugs; eg: 
intravenous metoclopramide, intravenous and intramuscular prochlorperazine may 
be considered as monotherapy for migraine.Oral antiemetics are suggested only for 
adjunctive use. 
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PREVENTIVE TREATMENTS OF MIGRAINE 
Preventive treatment is considered when the frequency of headache is so 
high that analgesic rebound is likely.It is also used when contraindications may limit 
the use and success of acute medications. 
GROUP 1 DRUGS: 
High proven clinical efficacy, mild to moderate adverse effects 
Group 1 drugs include divalproex sodium (anticonvulsant), amitryptiline 
(tricyclic antidepressant), propranalol and timolol. 
1.Divalproex sodium: 
 Class   : anticonvulsants 
Dose    : 500 – 1500 mg/day 
Side effects  : weight gain,tremor,alopecia,elevated liver enzymes 
Contraindications : hepatic disease 
Consider in patients with bipolar disorder, seizure disorder. 
2.Propranolol 
Class    : beta blocker 
Dose    : 80- 240 mg/day 
Side effects  : weight gain,syncope and depression 
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Contraindications : asthma, diabetes mellitus, depression 
Consider in patients with cardiovascular disease, hypertension 
3.Amitryptiline 
Class : tricyclic anti-depressant 
Dose : 50 -150 mg/day 
Side effects : dry eyes and mouth,drowsiness 
Avoided in patients with cardiac arrhythmias and elderly patients 
Consider in patients with depression. tension type headache 
GROUP 2 DRUGS 
They have lower efficacy than group 1 drugs. They include atenelol (beta 
blocker), verapamil (calcium channel blocker), aspirin(NSAIDS), gabapentin 
(anticonvulsants), flouxetine (selective serotonin reuptake inhibitors, 
antidepressant), magnesium. 
1.Gabapentin: 
Class    : anticonvulsant 
Dose    : 900 -2400 mg/day 
Side effects  : drowsiness,dizziness,weight gain 
Contraindications : no specific contraindications 
Considered in seizure disorder, neuropathic pain 
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2.Verapamil: 
Class    : calcium channel blocker 
Dose    : 240 mg/day 
Side effects  : hypotension, constipation 
Contraindications : orthostatic hypotension 
Consider in patients with cardiovascular disease, migraine aura 
GROUP 3 DRUGS 
Group 3 drugs have efficacy based only on clinical experience, but no 
scientific evidence. This group includes nortryptiline and protriptiline (tricyclic anti-
depressants), sertraline and paroxetine (selective serotonin reuptake inhibitors, 
antidepressants), topiramate (anticonvulsant). 
GROUP 4 DRUGS 
Group 4 drugs have medium to high efficacy but potentially significant side 
effects. They include flunarizine(anti emetic) and methysergide. 
GROUP 5 DRUGS 
Group 5 drugs have no evidence showing efficacy over placebo. This group 
includes clonidine (anti hypertensive), carbamazepine (anti convulsant) and 
indomethacin (NSAIDS). 
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OTHER DRUGS 
Botulinum toxin is used recently for treating migraine. Treatment protocol 
generally involves injections of botulinum toxin into the head, facial and cervical 
musculature. The presumed mechanism involves decreasing or eliminating 
peripheral activation and thereby reducing central trigeminovascular activation.But 
till date there is no class A evidence favoring the routine use of botulinum toxin in 
patients with migraine. 
OTHER TYPES OF HEADACHE 
A.TRIGEMINAL  CEPHALGIAS WITH AUTONOMIC FEATURES 
Pain is usually present in the distribution of the ophthalmic nerve. 
Autonomic features often involving eyes are present. The headache usually affects 
the same side of the face and the head. Autonomic manifestations include eyelid 
edema, conjunctival injection, tearing, Horners syndrome, rhinorrhea,nasal 
congestion and facial flushing. Because of the prominent ocular manifestations these 
patients often seek ophthalmic care early in their course. 
1.CLUSTER HEADACHE 
It is one of the most painful headache disorders and is the most common 
trigeminal autonomic cephalgia. 
INCIDENCE 
Less common than migraine affecting less than 1% of the population 
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AGE OF ONSET 
Between 27 and 31 years 
SEX 
The male to female ratio is 8:1 
GENETICS 
There seems to be a genetic component to cluster headaches in some 
families. It may affect monozygotic twins.However no specific gene is identified 
MECHANISM AND PATHOPHYSIOLOGY 
Both sympathetic(postganglionic Horners syndrome) and parasympathetic 
(lacrimation, rhinorrhea) nerves are affected. As in migraine there are both neuronal 
and vascular components.PET reveals bilateral activation in the region of the 
cavernous sinus, most prominent ipsilateral to headache, suggesting increased flow 
through cavernous portion of the carotid artery.MRI shows no abnormalities in the 
cavernous sinus area. The vascular changes may be due to trigeminal nerve 
activation as the observed features are not specific to cluster headache. 
The parasympathetic features likely arise from superior salivatory nucleus.It 
innervates cerebral blood vessels as well as lacrimal and nasal mucosal glands 
accounting for the lacrimation,nasal congestion and rhinorrhea. 
The trigeminovascular system involvement is evident by increased CGRP 
and VIP levels during attacks of cluster headache. 
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Suprachiasmatic nucleus also involved which regulates the rhythmic 
secretion of melatonin. 
CLINICAL FEATURES 
Pain quality  : stabbing, boring 
Pain  severity   : severe 
Site    : orbit and temple 
Attacks per day : upto 8 
Attack duration : 15 – 180 minutes 
Triggers  : alcohol, nitroglycerine, histamine, REM sleep 
Nocturnal attacks :  present 
Autonomic features : present 
Photophobia and phonophobia are not as predominant as migraine.Nausea 
may occur but vomiting rarely occurs.In contrast to migraine,where the patients 
prefer  to  lie  down  in  a  dark  quiet  room,patients  with  cluster  headache  are  restless  
and sometimes violent.They tend to pace,sit,rock,bang their head against the 
wall.The severity of the pain leads to suicidal thoughts 
 TYPES 
1. Episodic-extends from 7 days to 1 year. 
2. Chronic-extends for more than 1 year. 
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OPHTHALMIC FEATURES 
Horners syndrome, lacrimation, conjunctival injection(autonomic features) 
TREATMENT 
Acute phase: 
1. Inhaled oxygen within 15 min in 70% of patients. 
2. Subcutaneous sumatriptan 6 mg produces headache relief within 15 minutes 
3. IV dihydroergotamine 
4. Sumatriptan and zolmitriptan nasal spray 
Transitional prophylaxis: 
The main aim is to shorten the cluster period and to obtain rapid remission. 
And also to reduce the headache frequency and severity. 
1. Corticosteroids are used.Oral prednisolone (1 mg/kg body weight given only 
for  three  days)  or  dexamethasone  (4  mg  twice  daily  for  2  weeks  ,then  once  daily   
for 1 week) 
2. Ergotamine tartarate and dihydrotamine which is usually given for two or 
three weeks 
Drugs for maintenance prophylaxis: 
These drugs prevent recurrence during and after the transitional prophylaxis. 
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1. Verapamil starting at 240 mg daily and increasing to 720 mg daily in divided 
doses.  It  is  well  tolerated  at  very  high  doses.  The  common  side  effects  are  
constipation, dizziness, peripheral edema, hypotension and bradycardia. Periodic 
ECG monitoring is advised 
2. Lithium carbonate starting at 300 mg TDS or 450 mg sustained release. 
Common side effects are tremor, diarrhea and polyuria. Renal and thyroid functions 
should be monitored. Serum lithium concentrations and possible drug interactions 
should be monitored. 
3. Valproic acid(250 mg BD upto 2 g daily) 
4. Topiramate(50-125 mg daily) 
5. Melatonin (10 mg) 
6. Indomethacin is not much effective. 
7. Methysergide was earlier used but now withdrawn due to pulmonary, 
retroperitoneal and pericardial fibrosis. 
Surgery: 
Considered for patients with exclusively unilateral headaches that cannot be 
controlled with standard medications. 
1. Radiofrequency thermocoagulation of trigeminal ganglion is effective in 
75% of patients with 20% recurrence rate. Complete analgesia must be produced,so 
long term corneal care is critical to prevent neurogenic ulceration.Other 
complications include diplopia, icepick pain and anaesthesia dolorosa. 
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2. Trigeminal sensory rhizotomy at the root exit zone. 
3. Occiptal nerve stimulation 
4. Deep brain stimulation of hypothalamus 
PAROXYSMAL HEMICRANIA 
Paroxysmal hemicranias may begin at any age but commonly starts in the 
fourth decade and is not familial. It may be chronic or episodic. 
Pain quality  : throbbing, boring, stabbing 
Pain  severity   : severe 
Site    : orbit, temple 
Attacks per day : 1-40 
Attack duration : 2-25 min 
Triggers : alcohol, bending head, pressing on neck or occipital  
 nerve 
Nocturnal attacks : present 
Autonomic features : present 
Female:male ratio : 2:1 
OPHTHALMIC FEATURES 
1. Lid edema 
2. Conjunctival injection 
3. Horners syndrome 
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CHARACTERISTIC FEATURES 
More common in women and are absolutely indomethacin positive 
TREATMENT 
1. Indomethacin is usually started at 25 mg tds and gradually increased to  
50 mg tds. 
2. Successful treatment with aspirin, verapamil, steroids and naproxen has been 
reported. 
SHORT LASTING UNILATERAL NEURALGIFORM HEADACHES 
This syndrome is the rarest of the trigeminal autonomic cephalgias. 
Headache is usually short lasting. It is present for 15-120 seconds, occurring upto 
100 times daily. The pain is usually ocular. The pain starts and ends abruptly. Men 
are more commonly affected. Most patients have unilateral attacks and bilateral 
simultaneous attacks have also been reported. 
Pain quality  : burning,stabbing,electric 
Pain  severity   : Moderate 
Site    : periorbital 
Attacks per day : 6-77 
Attacks per day : 5-250 seconds 
Triggers  : trigeminal trigger points (hair, forehead, face, nose,  
    lip), facial and  neck movements. 
Nocturnal attacks : present 
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Autonomic features : present 
Female : male ratio : 1:2 
Age at onset is 23 to 77 years. Symptomatic periods may last from days to 
months. 
OPHTHALMIC FEATURES 
1. Conjunctival congestion 
2. Ptosis 
3. Lacrimation 
4. Lid edema 
Intaocular pressure and systolic blood pressure may be increased during the 
attacks. Intraorbital tumors, pituitary tumors, brainstem tumors and vascular 
malformations have been found in some patients. So neuroimaging is recommended 
for all patients. 
TREATMENT 
Treatment is largely ineffective. Most migraine preventive medications have 
been tried. Some success has been reported using lamotrigine, topiramate, 
carbamazepine, verapamil,valproate and nifedipine. 
SHORT LASTING HEADCHES(UNILATERAL AND NEURALGIFORM) 
The condition is extremely rare. It consists of severe, sharp, unilateral 
retroorbital headaches lasting from 40 to 80 seconds but occasionally upto 30 
minutes. Attacks occur 20 – 30 times daily without trigger points. There is a profuse 
unilateral tearing without other autonomic features. 
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Pain quality  : sharp 
Pain  severity   : severe 
Site    : retroorbital 
Attacks per day : 20-30 
Attack duration : 40-80 seconds(rarely upto 30 minutes) 
Triggers  : none 
Nocturnal attacks : absent 
Female:male ratio : unknown 
OPHTHALMIC FEATURES 
Lacrimation 
TREATMENT 
Gabapentin is minimally effective  
PRIMARY HEADACHE DISORDERS CAUSING OCULAR OR 
PERIOCULAR PAIN 
PRIMARY STABBING HEADACHE 
This type of headache is also known as icepick pains, jabs and jolts, 
ophthalmodynia periodica. It affects  1 -2% of the population. It occurs more 
frequently in patients with cluster headache, TTH, cervicogenic headache, 
hemicrania continua. Primary stabbing headache may start at any age and primarily 
affects women. 
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The attacks are very short, lasting a second and continues upto 10 seconds. 
The  pain  frequently  occurs  in  or  near  the  eye  but  tends  to  migrate.  There  are  
generally no provoking factors. The condition is generally benign. 
If the attacks are frequent enough to warrant prophylactic therapy, 
indomethacin, melatonin,celecoxib and amitryptilline are useful. 
HEMICRANIA CONTINUA 
Hemicrania continua is a continuous, unilateral headache that fluctuates in 
intensity. Young women are more commonly affected. Pain is generally located in 
the anterior head.It is usually dull aching or pressing type of pain. Some patients 
have autonomic symptoms such as conjunctival injection, lacrimation, nasal 
congestion. rhinorrhea, ptosis, lid edema. Photophobia, phonophobia, nausea and 
vomiting are common.There may be superimposed primary stabbing headaches. 
Patients are indomethacin responsive. 
INDICATIONS FOR NEUROIMAGING IN PATIENTS WITH HEADACHE 
1. The first or worst headache of patients life, particularly abrupt onset 
2. Change in frequency, severity or clinical features of migraine attack 
3. Neurological symptoms that donot meet criteria for migraine with aura 
4. Hemicrania that is always on the same side 
5. Positional headache 
6. No improvement with conventional therapy 
 
 
 
PART 2 
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AIMS AND OBJECTIVES 
To  elucidate  the  various  ophthalmic  manifestations  of  different  types  of  
migraine 
PRIMARY OBJECTIVES 
1. To  elucidate  the  various  ophthalmic  manifestations  of  different  types  of  
migraine 
2. To assess the response to treatment(with steroids) in Ophthalmoplegic 
migraine. 
3. To assess the visual field changes in migraine. 
4. OCT changes in migraine. 
SECONDARY OBJECTIVES 
1. Association with other ocular disorders 
STUDY DESIGN 
Prospective, clinical study 
PATIENT SELECTION 
All migraine cases with typical symptoms and signs in the period of 1 year 
by the method of random sampling.Age of inclusion was 5 to 60 years. Both genders 
were selected. 
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INCLUSION CRITERIA 
1. Patients with migraine (migraine with aura and migraine without aura). 
2. Retinal migraine 
3. Ophthalmoplegic migraine 
EXCLUSION CRITERIA 
1. Any other type of headache other than migraine 
2. Refractive errors. 
3. Head or eye trauma 
4. Eyes with retinal or optic disc pathology 
5. Cataract 
6. Corneal opacity 
7. Ocular laser treatment 
8. CNS disorders like brain tomours,infarction,encephalitis,parkinsons 
9. Diabetic and hypertensive retinopathy 
SAMPLE SIZE 
50 patients 
AGE 
5 to 60 yrs 
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STUDY PARAMETERS 
1. Detailed history of present and past illness 
2. Drug and treatment history 
3. Visual acuity using Snellen’s acuity chart 
4. Refraction 
5. Colour vision 
6. Slit lamp biomicroscopy of anterior segment 
7. Intraocular pressure using Goldmann Applanation tonometry 
8. Direct and indirect ophthalmoscopy 
9. Gonioscopy 
10. Automated perimetry 
11. Optical coherence tomography 
DATA COLLECTION AND METHODOLOGY 
50 patients based on the inclusion criteria were selected and evaluated 
subsequently. Various clinical findings of migraine were elucidated. All the above 
investigations were done. Follow up done at 1,4,6 weeks and late follow up at 3,6 
and 12 months 
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METHODS 
All patients included in the study were evaluated first by measuring the 
visual acuity using Snellens visual acuity chart at 6 meter distance. Detailed history 
was taken. History of headache (type, areas involved, association with vision loss, 
associations with aura, nausea, vomiting, field loss) and history of associated visual 
phenomena of migraine (scintillation scotoma, fortification spectra, micropsia, 
metamorphopsia, macropsia, pallinopsia, cerebral polyopia, Alice in wonderland 
syndrome, achromatopsia) were noted. History of visual snow and photophobia also 
noted.  Past  history  of  ophthalmic  (glaucoma  and  retinal  disease)  and  systemic  
diseases (diabetes, hypertension, epilepsy, cardiovascular disease, renal failure and 
CNS disorders).Treatment history noted(treatment for migraine or any other 
systemic diseases and the duration of treatment). 
Refraction was done for all patients. Anterior segment evaluation was done 
using slitlamp (lid edema, conjunctival congestion, Horners syndrome common in 
other types of headache other than migraine like cluster headache, paroxysmal 
hemicranias. short lasting unilateral neuralgiform headaches). 
Colour vision was checked for the patients in the study. Dilated fundus 
examination was done to rule out other retinal disorders like diabetic or hypertensive 
retinopathy, retinal detachment, macular disorders). 
Intraocular pressure was checked using Goldmann’s applanation tonometry. 
Angle study was done using gonioscopy. Fields  evaluated using standardized 
automated perimetry (Octopus).Optical coherence tomography was also done for all 
patients to see if there are any optic disc changes and retinal nerve fibre layer 
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thinning. These tests were helpful to find out if migraine is associated with any other 
ocular disorders like glaucoma. 
In ophthalmoplegic migraine , extraocular movements were checked and 
diplopia charting was done as it was associated with nerve palsies.Visual acuity, 
refraction, fields (using automated perimetry), colour vision, fundus (direct and 
indirect ophthalmoscopy) were checked. Patients were started with steroids along 
with anti migraine medications and its response to treatment was studied. 
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                                      OBSERVATION AND  RESULTS  
AGE 
Table 1:Age distribution of the study patients 
 
AGE IN YEARS NUMBER OF PATIENTS AND PERCENTAGE 
5-19 2(4 %) 
20-30 5(10 %) 
31-40 20(40 %) 
41-50 18(36 %) 
51-60 5(10 %) 
 
 Figure 1: Age distribution of study patients 
 
Out of the 50 patients examined,2 patients:5 years old (ophthalmoplegic 
migraine), 5 patients:20-30 years of age,20 patients:30-40 years of age,18 
patients:40-50 years of age  
5 patients:50-60 years of age. The mean age of presentation was around 
40.58 years of age. 
4%
10%
40%
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10%
5-19 yrs
20-30 yrs
31-40 yrs
41-50 yrs
51-60 yrs
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SEX 
Out of the 50 patients examined,36 patients were females(including the 
paediatric age group) and 14 patients were males. 
 Table 2:Sex distribution of the patients 
SEX NUMBER OF PATIENTS AND PERCENTAGE 
Males 14(28 %) 
Females 36(72 %) 
 
Figure 2: Sex distribution of the patients 
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VISUAL PHENOMENA 
All the patients were asked about the visual phenomena experienced by them 
during the attack of migraine. History of scintillation scotoma, fortification spectra, 
micropsia, macropsia, matamorphopsia, pallinopsia, cerebral polyopia, Alice in 
wonderland syndrome, achromatopsia were asked. 
Table 3:Visual phenomena of the patients in the study 
VISUAL PHENOMENA NUMBER OF PATIENTS 
Fortification spectra 1(2%) 
Scintillation scotoma 3(6%) 
Micropsia 2(4%) 
Macropsia 0 
Metamorphopsia 2(4%) 
Pallinopsia 2(4%) 
“Alice in wonderland” syndrome 2(4%) 
Cerebral polyopia 1(2%) 
Achromatopsia 0 
Visual Snow 1(2%) 
Kaleidoscopic vision 0 
Fragmented vision 1(2%) 
Mosaic vision 0 
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Figure 3:Visual phenomena in the study patients 
 
 
Out of the 50 patients examined 15 patients (30%) had some visual 
phenomena associated with migraine attacks. 
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OTHER ASSOCIATED VISUAL FEATURES 
Out of the 50 patients examined 9 patients had photophobia during a 
migraine attack. No patients had persistent visual field defects like homonymous 
hemianopia or tunnel vision or persistent loss of vision(negative symptoms.  
Table 4:Associated visual features in the study patients 
ASSOCIATED VISUAL 
FEATURES 
NUMBER OF PATIENTS AND 
PERCENTAGE 
Photophobia 9(18%) 
Negative symptoms 0 
 
Figure 4:Associated visual features in the study patients 
 
COLOUR VISION: 
All 50 patients examined had normal colour vision. 
18%
82%
Photophobia 
No photophobia 
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INTRAOCULAR PRESSURE 
Intraocular pressure was measured for all 50 patients by Goldmann’s 
applanation tonometry.IOP was within normal limits for all patients for both the 
eyes 
Table 5:Intraocular pressure of the study patients 
RE LE 
10-15 mmHg: 22 patients 10-15 mmHg:20 patients 
16-20 mmHg: 28 patients 16-20 mmHg:30 patients 
10 mmHg: 2(4%) 10 mmHg: 4(8%) 
12 mmHg: 8(16%) 12 mmHg: 6(12%) 
14 mmHg: 12(24%) 14 mmHg: 10(20%) 
16 mmHg: 5(10%) 16 mmHg: 9(18%) 
18 mmHg: 5(10%) 18 mmHg: 12(24%) 
20 mmHg: 18(36%) 20 mmHg: 9(18%) 
 
Figure 5:Intraocular pressure of the study patients 
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REFRACTION 
Retinoscopic refraction was done for all patients.Presbyopic correction was 
needed for 25 patients 
>35 years of age:2 patients 
>40 years of age:23 patients(18 patients:40-50 years of age,5 patients:50-60 years of 
age) 
FUNDUS EXAMINATION 
All patients in the study were subjected to dilated detailed fundus 
examination by direct, indirect ophthalmoscopy and slit lamp biomicroscopy using 
90D lens. 
BE Fundus was found to be normal for all patients.BE Peripheries was also 
found to be normal for all patients. 
GONIOSCOPY 
Shaffers grading of angles was done for all the 50 patients. Goldmann’s 
single mirror lens was used to grade the angles. All patients had open angles in both 
eyes. 
AUTOMATED PERIMETRY 
All  patients in the study were subjected to examination of visual fields using 
standardized automated perimetry (Octopus).All patients had normal visual fields in 
both eyes. 
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OPTICAL COHERENCE TOMOGRAPHY 
All patients underwent optic nerve head analysis and RNFL thickness testing 
RNFL THICKNESS REPORTS 
BE RNFL thinning noted in 25 patients(50%) (single quadrant thinning) 
RE RNFL thinning alone noted in 4 patients(8%) (single quadrant thinning) 
LE RNFL thinning alone noted in 4 patients(8%) (single quadrant thinning) 
BE more than 2 quadrants thinning noted in one patient(2%) 
Figure 6: RNFL thickness reports in the study patients 
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RE: 
Nasal quadrant thinning alone noted in 13 patients(26%).Out of which 12 
patients(24%) had BE thinning and 1 patient(2%) had RE thinning alone. 
Temporal quadrant thinning noted in 12 patients(24%).Out of which 11 
patients(22%) had BE thinning and 1 patient(2%) had RE thinning alone. 
Superior quadrant thinning noted in 1 patient(2%) with RE thinning alone. 
Inferior quadrant thinning noted in 1 patient(2%)with RE thinning alone. 
Inferior quadrant thinning noted in 2 patients(4%) with BE thinning(in RE) 
Figure 7:RNFL thinning in RE of the study patients(RE alone & RE thinning 
in BE involvement.The other eye involvement may be any quadrant)  
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LE: 
Nasal quadrant thinning alone noted in 10 patients(20%).Out of which 9 
patients(18%) had BE thinning and 1 patient(2%) had LE nasal quadrant thinning 
alone 
Temporal quadrant thinning noted in 14 patients(28%).Out of which 13 
patients(26%) had BE single quadrant thinning and 1 patient(2%) had LE temporal 
quadrant thinning alone. 
Inferior quadrant thinning noted in 3 patients(6%).Out of which 2 
patients(4%) had BE single quadrant thinning and one patient(2%) had LE inferior 
quadrant thinning alone 
Superior quadrant thinning noted in 2 patients(4%).Out of which 1 
patient(2%) had BE single quadrant thinning and 1 patient(2%) had LE superior 
quadrant thinning alone. 
Figure  8:RNFL  thinning  in  LE  of  the  study  patients(LE  alone  &  LE  
involvement in BE thinning.The other eye involvement may be any quadrant) 
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MULTIPLE QUADRANT THINNING 
Out of the 50 patients ,1 patient had superior,nasal and temporal quadrant 
thinning in RE and nasal ,temporal quadrant thinning in LE. 
Figure 9:Multiple quadrant thinning(BE) in the study patients 
 
OPHTHALMOPLEGIC MIGRAINE 
Out of the 50 patients examined 2 patients had ophthalmoplegic 
migraine.Both the patients were young female children of 5 years of age. 
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HISTORY 
One child was referred as a case of ophthalmoplegic migraine for ophthalmic 
evaluation.Another child attended our outpatient department with a classical 
history.Both the children presented with the following history 
Child 1: 
1. History of drooping of RE upper lid for 1 week duration, with no history of 
change in drooping while facial movements like chewing. No history of 
fluctuations and fatiguability. 
2. History of headache for 1 week duration. It was throbbing in nature, more in 
the right frontal region with history of intolerance to the noisy environment 
and head banging over walls (temper tantrums) 
3. History of defective vision RE for 1 week duration mainly for distance 
Child 2: 
1. History of drooping of LE upper lid for 5 days duration, with no history of 
change in drooping while facial movements like chewing.No history of 
fluctuations and fatiguability. 
2. History of headache for 5 days duration. It was throbbing in nature, more in 
the left frontal region with history of intolerance to the noisy environment. 
3. History of defective vision LE for the past 5 days mainly for distance 
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Both the children had no history of seizures, loss of consciousness, head 
injury, neck stiffness. No history suggestive of 1,2,4,5,6,7,9,11,12 th cranial nerves 
involvement. There was no history of weakness of upper and lower limbs, difficulty 
in speech or swallowing or walking. There was no history of reduced sensations 
over any part of the body. There was no history of fever or trauma or loose stools. 
PAST HISTORY 
First child had recurrent attacks of right sided headache on and off for the 
past one and half years and was diagnosed as a case of migraine. She was treated 
with oral  propranalol. Patient was asked to continue the medications but defaulted. 
There was no history of sinusitis or systemic illness like tuberculosis. 
Second  child  was  diagnosed  as  a  case  of  migraine  and  she  was  on  regular  
medications(T. Propranalol 40 mg ½ TDS and T.Amitryptilline 10 mg ¼ HS). 
Antenatal, natal, postnatal, developmental, immunization history were 
normal for both the children 
FAMILY HISTORY 
The mother of the first child had migraine since she was 15 years of age.But 
she was on irregular treatment 
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ANTERIOR SEGMENT EXAMINATION 
Child 1: 
Facial asymmetry was present. 
Head posture:normal 
Right eye  Left eye 
6/24 NIP Vision 6/9 NIP 
All movements except 
abduction and intorsion 
restricted 
Extraocular 
movements 
Full 
Clear Conjunctiva Clear 
Clear Cornea Clear 
Normal depth Anterior chamber Normal depth 
Normal colour pattern  Iris Normal colour pattern 
Sluggishly reacting to 
light,4 mm 
Pupil 3  mm  reacting  to  direct  and  
consensual light reflexes 
Clear Lens Clear 
Normal  Fundus Normal  
Normal  Colour vision Normal  
 
 
 
 
 
64 
Child 2 
Facial asymmetry was present. 
Head posture was normal 
 
RIGHT EYE  LEFT EYE 
6/6 Vision 6/12 NIP 
Full Extraocular movements All movements except 
intorsion and abduction 
restricted 
Clear Conjunctiva Clear 
Clear Cornea Clear 
Normal depth Anterior chamber Normal depth 
Normal colour pattern Iris Normal colour pattern 
3 mm reacting to both 
direct and consensual 
light reflexes 
Pupil 4mm,sluggishly reacting 
to light 
Clear Lens Clear 
Normal Fundus Normal 
Normal  Colour vision Normal 
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ORTHOPTIC EVALUATION 
Child 1: 
1. Done after retracting RE upper lid. 
2. Cover test : RE divergent squint with hypotropia 
3. Extraocular movements: All movements except abduction and intorsion 
restricted 
4. Prism  bar  cover  test  :  FR  Exotropia  >  90  prism  dioptres,  FL  30  prism  
dioptres. 
5. Secondary deviation more than primary deviation. 
Child 2: 
1. Done after retracting LE upper lid. 
2. Cover test:LE divergent squint with hypotropia 
3. Extraocular movements : All movements except abduction and intorsion 
restricted. 
4. Prism bar cover test : FR exotropia 30 prism dioptres, FL 90 prism dioptres 
5. Secondary deviation more than primary deviation 
PTOSIS EVALUATION: 
Both the children had complete ptosis (first child had RE ptosis and second 
child had LE ptosis). Lid crease was present in both the children. Ice pack and 
fatiguability tests were negative in both the children. There was no lagophthalmos 
and bells phenomenon was intact in both the children.  
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DIPLOPIA CHARTING 
Both the children had crossed diplopia on opening the ptotic lid. 
NEUROLOGIST OPINION: 
Both  the  children  were  advised  MRI  with  contrast.CSF  analysis,  thyroid  
profile and vasculitis work up 
INVESTIGATIONS TAKEN: 
1. BASELINE 
CHILD 1 INVESTIGATIONS CHILD 2 
11.6 g/dl Hemoglobin 11 g/dl 
10,800 cells/cubic mm Total count 10,200 cells/cubic mm 
P 48% L 52% Differential count P 48% L 52% 
3,75,000/cubic mm Platelet count 3,50,000/cubic mm 
33.3% Packed cell volume 36% 
22 mg/dl Blood urea 25 mg/dl 
0.5 mg/dl Serum creatinine 0.4 mg/dl 
138 mEq/L Serum sodium 140 mEq/L 
4.2 mEq/L Serum potassium 3.9 mEq/L 
28 IU/ml SGOT 36 IU/L 
29 IU/ml SGPT 32 IU/L 
Normal  Chest X ray Normal  
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2.VASCULITIS WORKUP 
CHILD 1  CHILD 2 
6 mm/16 mm ESR 7 mm/12 mm 
Negative CRP Negative 
Negative ANA Negative 
Negative ANCA Negative 
Negative  RF Negative  
 
3.THYROID PROFILE 
CHILD 1  CHILD 2 
99.56 ng/dl Serum T3 110 ng/dl 
8.02 micrograms/dl Serum T4 6.5 micrograms/dl 
2.670 mIU/ml Serum TSH 3.25 mIU/ml 
      
 4.NEUROIMAGING 
CHILD 1 NEUROIMAGING CHILD 2 
Normal CT brain with angiography Normal 
Normal MRI brain Normal 
Normal  MRA & MRV Normal 
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5.CSF ANALYSIS 
CHILD 1 CSF ANALYSIS CHILD 2 
56 mmol/L Glucose 58 mmol/L 
90 g/L Protein 85 g/L 
No growth Culture & sensitivity No growth 
P  0% L 1%E 0% Cell count P 0% L 1% E 0% 
Negative Latex Negative 
 
6.METABOLIC PARAMETERS 
CHILD 1 METABOLIC PARAMETERS CHILD 2 
0.52 mmol/L Serum lactate  0.48 mmol/L 
9.0 micromol/L Serum ammonia 8.4 micromol/L 
50 mg Urine porphyrin 52 mg 
 
7.OTHERS 
CHILD 1  CHILD 2 
C3=96.1 mg/dl,  
C4=18.5 mg/dl 
Complement 
factors 
C3=92.5 mg/dl,  
C4=18.5 mg/dl 
Normal  Echocardiogram  Normal  
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TREATMENT GIVEN 
Both the children were treated with 
1. T.Propranalol 40 mg ½ TDS 
2. T.Amitryptilline 10 mg HS 
3. T.Prednisolone 20 mg was started and continued for 15 days  and then 
gradually tapered for the next 1 month. 
4. T.Ranitidine 150 mg ½ BD 
FOLLOW UP 
Both the children were followed up for the next 3 months 
After 1 month: 
Child 1:  RE ptosis recovered completely. Movements in RE recovered 
partially.RE pupil was reacting to both direct and consensual light reflexes.There 
was residual exo 45 prism dioptres in the RE. 
Child 2: LE  ptosis recovered completely. Movements in LE recovered 
partially. LE pupil was reacting to both direct and consensual light reflexes. There 
was residual exo 30 prism dioptres in the LE. 
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After 2 months: 
Child 1 & 2 
Vision(BE):6/6                                                                                                                                                                
Colour vision(BE):Normal 
EOM:Full 
Diplopia charting:No diplopia 
Fundus(BE):Media clear 
Disc and vessels:normal 
Macula:FR present 
There was residual exo of 15 prism dioptres RE for the first child and 10 prism 
dioptres in the LE for the second child 
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                           A CASE OF OPHTHALMOPLEGIC MIGRAINE 
 
 
                           
 
 
 
 
Figure 10 a                                        Figure 10 b 
 
Figure 10 a: 5 yr old child with RE ophthalmoplegic  migraine(ptosis was present) 
Figure 10 b: Restriction of adduction in RE,pupil:4 mm sluggishly reacting to 
light.Vision(RE):6/24 NIP;(LE):6/9 NIP                                                                                             
 
 
 
 
 
 
                   
Figure 10 c      Figure 10 d 
Figure 10 c: Restriction of elevation in RE 
Figure 10 d: Restriction of depression in RE 
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A CASE OF OPHTHALMOPLEGIC MIGRAINE 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10 e: Abduction was full in RE 
 
FOLLOW UP AFTER 1 MONTH(PATIENT STARTED ON STEROIDS) 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11: Ptosis recovered fully.Extraocular movements recovered partially.There 
was residual exo of 45 prism dioptres in RE.Pupil was reacting to both direct and 
consensual light reflexes. 
73 
                                FOLLOW UP AFTER 2 MONTHS  
                                          
 
 
 
 
Figure 12 a: The child had residual exo of 15 prism dioptres in RE,with vision 
6/6,BE pupils reacting to light reflexes 
                      
 
 
 
 
 
                      Figure 12 b: Abduction and adduction were full 
 
                       
                  
 
 
 
 
Figure 12 c:Elevation and depression were full 
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DISCUSSION 
The study was conducted in a tertiary care hospital and 50 patients based 
upon the inclusion criteria were selected. 
Out of the 50 patients,2 patients belonged to paediatric age group(5 years of 
age).They were diagnosed as ophthalmoplegic migraine after all the necessary 
investigations and treatment was given. The mean age of presentation was 5 years of 
age. All the patients were subjected to a list of investigations. 
Out of the 50 patients,10% of patients belonged to 20-30 years of age.40% of 
patients belonged to 31-40 years of age.36% of patients belonged to 41-50 years of 
age.10% of patients belong to 51-60 years of age.The mean age of presentation was 
around 40.58 years of age. 
Out of the 50 patients,28% of patients were males and 72% of patients were 
females. So according to the study, females were more commonly affected than 
males. 
Out of the 50 patients examined,2% of patients had fortification spectra.6% 
of  patients  had  scintillation  scotoma.4%  had  micropsia.4%  of  patients  had  
metamorphopsia.4% of patients had pallinopsia.4% of patients had “Alice in 
wonderland”syndrome.2% of patients had cerebral polyopia.2% of patients had 
visual snow.2% of patients had fragmented vision. 
Totally around 30% of patients had visual phenomena associated with 
migraine attacks. 
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Around 18% of patients had photophobia. 
All patients had normal colour vision, normal range of intraocular pressure. 
Gonioscopy showed open angles for all patients. 
Fundus was found to be normal in all patients. Peripheries were found to be 
normal in all patients. 
Refraction was done in all patients.Presbyopic correction was given to 25 
patients. 
Automated perimetry was found to be normal in all patients. 
Optical coherence tomography was done in all patients. BE RNFL thinning 
(single quadrant thinning)was found in 50% of patients.RE RNFL thinning (single 
quadrant thinning)was found in 8% of patients. LE RNFL thinning(single quadrant 
thinning) was found in 8% of patients. BE more than 2 quadrants thinning noted in 
2% of patients 
In the RE, nasal quadrant thinning alone is noted in 26% of patients. Out of 
which 24% of patients had BE thinning and 2% had RE thinning alone. Temporal 
quadrant thinning noted in 24% of patients. Out of which 22% of patients had BE 
thinning and 2% of patients had RE thinning alone. Superior quadrant thinning 
noted in 2% of patients with RE thinning alone. Inferior quadrant thinning noted in 
2% of patients with RE thinning alone. Inferior quadrant thinning noted in 4% of 
patients with BE thinning(in RE) 
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In LE, nasal quadrant thinning alone noted in 20% of patients. Out of which 
18% of patients had BE RNFL thinning and 2% of patients had LE nasal quadrant 
thinning alone. Temporal quadrant thinning noted in 28% of patients. Out of which 
26% of patients had BE single quadrant thinning and 2% of patients had LE 
temporal quadrant thinning alone. Inferior quadrant thinning noted in 6% of patients. 
Out of which 4% of patients had BE single quadrant thinning and 2% of patients LE 
inferior quadrant thinning alone. Superior quadrant thinning noted in 4% of patients. 
Out of which 2% of patients had BE single quadrant thinning and 2% of patients had 
LE superior quadrant thinning alone. 
Out of the 50 patients,2% of patients  had multiple quadrant thinning. 
Out of the 50 patients examined,2 patients had ophthalmoplegic migraine. 
Both the children were young female children of 5 years of age. Both the children 
presented with history of  throbbing headache ,drooping of upper eyelid (RE for the 
first  child  and  LE  for  the  second  child)  of  acute  onset  and  short  duration.  All  
extraocular movements except intorsion and abduction were restricted(RE in first 
child and LE in second child).Both the children had ptosis (RE for the first child and 
LE for the second child).Both the children had past history of migraine. Incomitant 
squint (RE for the first child and LE for the second child) was present in both the 
children. Both the children had crossed diplopia on opening the ptotic lid. Both the 
children were subjected to baseline, metabolic, thyroid profiles, CSF analysis, 
neuroimaging. All investigations found to be normal. Neurologist and cardiologist 
opinions were obtained. Both the children were started with T.Prednisolone 20 mg 1 
OD, continued for 15 days and tapered gradually for the next 1 month. They were 
advised to continue T.Propranalol 40 mg ½ TDS, T.Amitryptilline 10 mg HS. Both 
the children gradually improved and became normal after 2 months(BE 
vision:6/6,ptosis improved completely, EOM:full, no diplopia) 
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CONCLUSION 
The visual phenomena which occurs in migraine is due to the cortical 
spreading depression. Aura symptoms are produced in relation to the areas of 
cerebral cortex affected. Primary and visual association cortex is associated with 
visual symptoms of migraine. 
The mean age of presentation of migraine  was 40.58 years of age in the 
study. It was more common in females than males. Visual phenomena associated 
with  migraine  was  present  in  30%  of  patients  with  migraine.  Photophobia  was  
present in 18% of patients. Colour vision, fundus, automated perimetry, slit lamp 
examination, gonioscopy were found to be normal in all patients. RNFL thinning 
was noted by OCT in BE- 50% of patients(single quadrant thinning), RE:8% of 
patients (single quadrant thinning),LE:8% of the patients(single quadrant 
thinning),multiple quadrant thinning:2% of patients. 
All  patients  were  already  on  treatment  with  T.Propranalol  40  mg(either  ½  
BD or 1 BD), T.Amitryptilline 25 mg(either ½ HS or 1 HS),T.Para 500 mg s-o-s as 
directed by the neurologist. Patients who experienced visual phenomena did so when 
they missed medications (more when they were on irregular treatment) 
Patients with ophthalmoplegic migraine responded to treatment with steroids 
and completely recovered in 2 months. The mean age of presentation was 5 years of 
age. These patients belonged to paediatric age group(in our study only 2 patients of 
the 50 patients had ophthalmoplegic migraine).The mean age of presentation was 5 
years.  The  incidence  of  the  disease  was  less  according  to  our  study  as  well  as  the  
literature. The response to steroids proved that ophthalmoplegic migraine is an 
inflammatory demyelinating neuropathy. 
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CASE PROFORMA 
NAME 
AGE: 
SEX:  MALE/FEMALE 
OP/IP NO: 
ADDRESS: 
PRESENTING COMPLAINTS: 
Headache, defective vision, drooping of upper lid (ophthalmoplegic migraine) 
HISTORY OF PRESENTING ILLNESS 
1.HEADACHE: 
Duration, onset, type any radiation, any associated visual phenomena, any nausea or 
vomiting 
2.VISUAL PHENOMENA: 
Scintillationscotoma, fortification spectra, micropsia, macropsia, metamorphopsia, 
pallinopsia, cerebral polyopia, achromatopsia, visual snow, Alice in Wonderland 
syndrome 
3.ASSOCIATED VISUAL FEATURES 
Photophobia, negative symptoms(field loss, tunnel vision) 
4.DROOPING OF UPPER LID(IN OPHTHALMOPLEGIC MIGRAINE) 
Duration, onset, any diurnal variations or fatiguability 
 
5.DEFECTIVE VISION(IN OPHTHALMOPLEGIC MIGRAINE) 
PAST HISTORY 
Diabetes, hypertension, bronchial asthma, COPD, coronary artery disease, 
tuberculosis, renal disorder, thyroid disorder, drug abuse 
PERSONAL HISTORY 
Smoking, alcoholism, diet intake 
FAMILY HISTORY 
Family history of migraine is asked 
GENERAL EXAMINATION 
OCULAR EXAMINATION 
      RE     LE 
LIDS: 
Ptosis (ophthalmoplegic migraine) 
Edema (autonomic features of migraine) 
CONJUNCTIVA 
Congestion (autonomic features of migraine) 
CORNEA 
 
ANTERIOR CHAMBER 
IRIS 
 
     RE     LE 
 
PUPIL 
Size, shape 
Reaction to light  
(important in ophthalmoplegic migraine) 
LENS 
EXTRAOCULAR MOVEMENTS 
OCULAR INVESTIGATIONS 
VISUAL ACUITY 
REFRACTION 
FUNDUS(DIRECT,INDIRECT OPHTHALMOSCOPY) 
AUTOMATED PERIMETRY 
OPTICAL COHERENCE TOMOGRAPHY(RNFL THICKNESS REPORTS) 
ADDITIONAL INVESTIGATIONS IN OPHTHALMOPLEGIC MIGRAINE 
1.Baseline 
2.Thyroid profile 
3.CSF analysis 
4.Neuroimaging 
5.Vasculitis work up 
6.Metabolic parameters 
7.Others like complement factors,echocardiogram 
DIPLOPIA CHARTING(OPHTHALMOPLEGIC MIGRAINE) 
ORTHOPTIC EVALUATION(OPHTHALMOPLEGIC MIGRAINE) 
  
 
 
 
 
MASTER CHART 
 
 
 
 
 
 
 
 
 
 
 
S.NO PATIENT NAME AGE SEX
DURATION 
OF MIGRAINE TREATMENT
VISUAL 
PHENOMENA
ASSOCIATED
 VISUAL 
FEATURES
REFRACTION
TN/RE
 & LE
COLOUR
VISION FUNDUS GONIOSCOPY FIELDS OCT
1 KALA 40 F 8Y PAP S 12 & 14 N N O N 1,N,N
2 POOGAVANAM 34 F 15Y PAP 2 0 & 20 N N O N 1,N,T
3 PREMAVATHY 30 F 5Y PAP 12 & 14 N N O N
4 JOHNSON 40 M 15Y PAP NV 20 & 14 N N O N 1,N,N
5 SARASWATHY 36 F 5Y AP 12 & 20 N N O N 1,N,T
6 SARALA 35 F 7Y PAP 14 & 20 N N O N 3,S
7 RAJESWARI 49 F 20Y PAP NV 10 & 20 N N O N 1,T,N
8 LAKSHMI 38 F 4Y PA S NV 14 & 20 N N O N 1,N,N
9 PARANTHAMAN 46 M 5Y PA MM NV 22 & 14 N N O N 1,T,N
10 NATARAJ 45 M 5Y AP NV 12 & 16 N N O N 3,I
11 SHAKELA 55 F 6Y AP NV 20 & 16 N N O N 1,N,T
12 FIROZBANU 28 F 2Y AP P 14 & 12 N N O N 1,T,I
13 JAYANTHI 26 F 5Y AP P 12 & 16 N N O N 1,N,T
14 BALAMANI 49 F 6Y PAP NV 20 & 20 N N O N 3,T
15 PARIMALA 37 F 7Y PAP 20 & 16 N N O N 1,N,T
16 SHANMUGAM 59 M 10Y PAP NV 10 & 20 N N O N 1,N,T
17 SIVAGAMI 40 F 5Y PAP NV 20 & 14 N N O N 3,N,T
18 JAHEEDA 38 F 5Y PAP 20 & 14 N N O N 1,T,I
19 GOVINDAMMAL 56 F 10Y PAP 20 & 20 N N O N 1,T,S
20 LAKSHMI 75 F 9Y PAP NV 20 & 12 N N O N 1,T,T
21 THAMAYANDHI 27 F 5Y PAP AS 20 & 20 N N O N 2,S
22 SARAWATHY 52 F 5Y PAP NV 12 & 18 N N O N 1,N,N
23 MARINA 41 F 10Y PAP AS NV 14 & 18 N N O N 1,N,T
24 PARAMESWARI 43 F 5Y PAP NV 14 & 14 N N O N 1,N,N
25 VALLI 40 F 6Y PAP Mi NV 20 & 12 N N O N 2,N
26 CHINTHAMANI 43 F 7Y PAP P NV 16 & 14 N N O N 2,T
27 LAKSHMI 66 F 5Y PAP P NV 16 & 18 N N O N 1,T,T
28 MAHESH 27 M 6Y PAP CO 20 & 18 N N O N 4
29 LOGESWARI 32 F 7Y AP 12 & 18 N N O N 1,T,T
30 RAMAKRISHNAN 37 M 5Y PAP Mi P NV 14 & 14 N N O N 1,T,T
31 DHARINI 45 F 7Y PA NV 16 & 12 N N O N 1,T,T
32 SHREE VIDHYA 33 F 5Y PAP 16 & 18 N N O N 1,T,N
33 ARJUNAN 48 M 10Y AP S P NV 20 & 18 N N O N
34 RAJENDRAN 31 M 10Y PAP P 20 & 16 N N O N 1,T,N
35 SUMANGALI 42 F 5Y P NV 14 & 18 N N O N
36 PRABHU 37 M 7Y 14 & 18 N N O N
37 SAROJINI 31 F 7Y F 16 & 18 N N O N
38 ARPUDHA MARY 38 F 8Y P 20 & 16 N N O N
39 MAHENDRAN 43 M 10Y VS NV 20 & 16 N N O N
40 RAGUNATHAN 46 M 12Y P NV 14 & 18 N N O N
41 AYESHA BEEVI 48 F 15Y MM NV 20 & 18 N N O N 1,T,T
42 SHAHUL AHMED 33 M 10Y FV 14 & 16 N N O N 2,S
43 BANUMATHI 49 F 15Y NV 20 & 16 N N O N
44 PRIYADARSHINI 36 F 6Y NV 20 & 12 N N O N
45 VARADARAJAN 41 M 10Y NV 16 & 12 N N O N
46 JANAKI 43 F 5Y 14 & 10 N N O N
47 BHARATHI RAJ 36 M 10Y 14 & 10 N N O N
48 RANI 38 F 8Y P N N O N
S.NO
PATIENT NAME   
(OPHTHALMOPLEGIC
 MIGRAINE )
AGE SEX
DURATION 
OF MIGRAINE TREATMENT EOM DIPLOPIA REFRACTION
TN
/RE & LE
COLOUR 
VISION FUNDUS GONIOSCOPY FIELDS ORTHOPTICS
1 RISWANA BEGUM 5 F 3Y SPAP A,E,D,EX CD 6/24,6/9 10 & 12 N N O N IS
2 LAKSHMI 5 F 1Y SPAP A,E,D,EX CD 6/6,6/12 12 & 14 N N O N IS
                                          KEY TO MASTER CHART 
NAME 
AGE  
SEX    
M  - Male 
F - Female 
DURATION OF MIGRAINE 
Number 
y - years 
m - months 
d - days 
VISUAL PHENOMENA 
Fortification spectra - F 
Scintillation scotoma - S 
Micropsia   - Mi 
Macropsia  - Ma 
Metamorphopsia - MM 
Pallinopsia  - P 
“Alice in wonderland syndrome” - AS 
Cerebral polyopia - C 
Achromatopsia - A 
Visual snow  - V S 
Kaleidoscope vision - KV 
Fragmented vision - FV 
Mosaic vision  - MV 
REFRACTION 
NV   - Near vision add for the patient 
ASSOCIATED VISUAL FEATURES 
Photophobia  - P 
Negative symptoms - N 
 
COLOUR VISION 
N - Normal 
Abn - Abnormal 
GONIOSCOPY 
O - Open angles 
C - Closed angles 
IOP 
Numbers indicate the measurement in mmHg 
FUNDUS 
N - normal 
Abn - abnormal 
OCT 
RNFL THINNING 
BE   - 1 
RE ALONE - 2 
LE ALONE - 3 
BE MULTIPLE QUADRANT THINNING:4 
Superior quadrant thinning - S 
Inferior quadrant thinning - I 
Nasal quadrant thinning - N 
Temporal quadrant thinning - T 
If BE involved, RE finding first followed by LE 
TREATMENT 
Steroids - S 
Propranalol - P 
Amitryptilline - A 
Paracetemol - P 
DIPLOPIA  
UD  - Uncrossed diplopia 
CD   - Crossed diplopia 
EOM_Extraocular movements 
A - adduction restriction 
E - Elevation restriction 
D - Depression restriction 
EX - Extorsion restriction 
ORTHOPTICS 
IS - incomitant squint 
CS - concomitant squint 
 
 
